Artificial immune system: methods for making and use

Details Artificial immune system: methods for making and use Artificial immune system: methods for making and use

2005-04-28

2010-12-21

Belyavskyi, Michail A (Department: 1644)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Primate cell, per se

C435S373000

Reexamination Certificate

active

07855074

ABSTRACT:
The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the normal tissues that interact with vaccines in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interaction with the immune system.

REFERENCES:
patent: 5008116 (1991-04-01), Cahn
patent: 5160490 (1992-11-01), Naughton et al.
patent: 5354686 (1994-10-01), Haberman
patent: 5562910 (1996-10-01), Daynes et al.
patent: 5725856 (1998-03-01), Hudziak et al.
patent: 5739001 (1998-04-01), Brown et al.
patent: 5750329 (1998-05-01), Quinn et al.
patent: 6177282 (2001-01-01), McIntyre
patent: 6274378 (2001-08-01), Steinman et al.
patent: 6479064 (2002-11-01), Atala
patent: 6835550 (2004-12-01), Estell et al.
patent: 2002/0155108 (2002-10-01), Barbera-Guillem et al.
patent: 2003/0109042 (2003-06-01), Wu et al.
patent: 2003/0147923 (2003-08-01), Klaviniskis
patent: 2003/0199006 (2003-10-01), Britz et al.
patent: 2003/0207287 (2003-11-01), Short
patent: 2004/0009943 (2004-01-01), Semple et al.
patent: 2004/0109876 (2004-06-01), Yamamoto et al.
patent: 2004/0234510 (2004-11-01), Mochitate
patent: 2005/0191743 (2005-09-01), Wu et al.
patent: 2005/0229264 (2005-10-01), Chang et al.
patent: 2005/0282148 (2005-12-01), Warren et al.
patent: 2006/0105454 (2006-05-01), Son et al.
patent: 2006/0270029 (2006-11-01), Warren et al.
patent: 2006/0275270 (2006-12-01), Warren et al.
patent: 2007/0015136 (2007-01-01), Sanchez-Schmitz et al.
patent: 2007/0141552 (2007-06-01), Warren et al.
patent: 2007/0154956 (2007-07-01), Warren et al.
patent: 2007/0178076 (2007-08-01), Drake et al.
patent: 2007/0218054 (2007-09-01), Sukumar et al.
patent: 2008/0008653 (2008-01-01), Tew et al.
patent: 0 358 506 (1989-09-01), None
patent: 1 437 147 (2002-09-01), None
patent: 1970444 (2006-12-01), None
patent: WO 99/15629 (1999-04-01), None
patent: WO 99/43788 (1999-09-01), None
patent: WO99/49319 (1999-09-01), None
patent: WO 03/041568 (2003-05-01), None
patent: WO 2003/041568 (2003-05-01), None
patent: WO 2003/050271 (2003-06-01), None
patent: WO 2004/031361 (2004-04-01), None
patent: WO2004/101773 (2004-11-01), None
patent: WO 2005/104755 (2005-11-01), None
patent: WO 2007/075979 (2007-07-01), None
patent: WO 2007/106559 (2007-09-01), None
patent: WO 2007/146267 (2007-12-01), None
Dorland Medical Dictionary, 2007, p. 1.
Stendma's Medical Dictionary , 2007, p. 1.
Dorlands Medical Dictionary, 2008, pp. 1 and 2.
U.S. Appl. No. 11/375,033, filed Mar. 15, 2006, Warren et al.
U.S. Appl. No. 11/375,128, filed Mar. 15, 2006, Warren et al.
U.S. Appl. No. 11/471,514, filed Jun. 21, 2006, Sanchez-Schmitz et al.
U.S. Appl. No. 11/453,046, filed Jun. 15, 2006, Warren et al.
U.S. Appl. No. 11/453,003, filed Jun. 15, 2006, Warren, et al.
Suematsu, et al., “Generation of a Synthetic Lymphoid Tissue-Like Organoid in Mice”, Nature Biotechnology, vol. 22, No. 12, pp. 1539-1545 (Dec. 2004).
Randolph, et al., “Role of Tissue Factor in Adhesion of Mononuclear Phagocytes to and Trafficking Through Endothelium in Vitro”, Blood, vol. 92, pp. 4167-4177 (1998).
Randolph, et al., “Differentiation of Monocytes into Dendritic Cells in a Model of Transendothelial Trafficking”, Science, vol. 282, pp. 480-483 (1998).
Randolph, et al., “A Physiologic Function for p-Glycoprotein (MDR-1) During the Migration of Dendritic Cells from Skin Via Afferent Lymphatic Vessels”, Proc. Natl. Acad. Sci., vol. 95, pp. 6924-2929 (1998).
Randolph, et al., “The CD16(+) (FcγRIII(+)) Subset of Human Monocytes Preferentially Becomes Migratory Dendritic Cells in a Model Tissue Setting”, J. Exp. Med., vol. 196, No. 4, pp. 517-527 (2002).
Randolph, et al., Mononuclear Phagocytes Egress from an In Vitro Model of the Vascular Wall by Migrating Across Endothelium in the Basal to Apical Direction: Role of Intercellular Adhesion Molecule 1 and the CD11/CD18 Integrins; J. Exp. Med., vol. 183, pp. 451-462 (1996).
Randolph, et al., “A Soluble Gradient of Endogenous Monocyte Chemoattractant Protein-1 Promotes the Transendothelial Migration of Monocytes In Vitro”, The Journal of Immunology, vol. 155, pp. 3610-3618 (1995).
Furie, et al., “Migration of Neutrophils Across Endothelial Monolayers is Stimulated by Treatment of the Monolayers with Interleukin-1 or Tumor Necrosis Factor-Alpha”, The Journal of Immunology, vol. 143, pp. 3309-3317 (1989).
Robbiani, et al., “The Leukotriene C4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)-Dependent Mobilization of Dendritic Cells to Lymph Nodes”, Cell, vol. 103, pp. 757-768 (2000).
Podgrabinska, et al., “Molecular Characterization of Lymphatic Endothelial Cells”, Proc. Natl. Acad. Sci. U.S.A., vol. 99, No. 25, pp. 16069-16074 (2002).
Berman, et al., “Roles of Platelet/Endothelial Cell Adhesion Molecule-1 (PECAM-1, CD31) in Natural Killer Cell Transendothelial Migration and Beta 2 Integrin Activation”, The Journal of Immunology, vol. 156, pp. 1515-1524 (1996).
Gergel, et al., “Activation of Endothelium byBorrelia burgdorferiIn Vitro Enhances Transmigration of Specific Subsets of T Lymphocytes”, Infection and Immunity, vol. 69, pp. 2190-2197 (2001).
Qu, et al., “Autocrine Type I IFN and Contact with Endothelium Promote the Presentation of Influenza A Virus by Monocyte-Derived APC”, The Journal of Immunology, vol. 170, pp. 1010-1018 (2003).
Mellman, et al., “Dendritic Cells: Specialized and Regulated Antigen Processing Machines”, Cell, vol. 106, pp. 255-258 (2001).
Lukas, et al., “Human Cutaneous Dendritic Cells Migrate Through Dermal Lymphatic Vessels in a Skin Organ Culture Model”, The Journal of Investigative Dermatology, vol. 106, pp. 1293-1299 (1996).
Fransson, et al., “Culture of Human Epidermal Langerhans Cells in a Skin Equivalent”, British Journal of Dermatology, vol. 139, pp. 598-604 (1998).
Banchereau, et al., “Immunobiology of Dendritic Cells”, Annu. Rev. Immunol., vol. 18, pp. 767-811(2000).
Butcher, et al., “Lymphocyte Trafficking and Regional Immunity”, Advances in Immunology, vol. 72, pp. 209-253 (1999).
Sprent, et al., “Antigen-Induced Selective Recruitment of Circulating Lymphocytes”, Cellular Immunology, vol. 2, pp. 171-181 (1971).
Garside, et al., “Visualization of Specific B and T Lumphocyte Interactions in the Lymph Node”, Science, vol. 281, pp. 96-99 (1998).
Jenkins, et al., “In Vivo Activation of Antigen-Specific CD4 T Cells”, Annu. Rev. Immunol., vol. 19, pp. 23-45 (2001).
Kaldjian, et al., “Spatial and Molecular Organization of Lymph Node T Cell Cortex: A Labyrinthine Cavity Bounded by an Epithelium-Like Monolayer of Fibroblastic Reticular Cells Anchored to Basement Membrane-like Extracellular Matrix”, International Immunology, vol. 13, pp. 1243-1253 (2001).
Gretz, et al., “Sophisticated Strategies for Information Encounter in the Lymph Node: The Reticular Network as a Conduit of Soluble Information and a Highway for Cell Traffic”, The Journal of Immunology, vol. 157, pp. 495-499 (1996).
Van Den Berg, et al., “Localization of β1 Integrins and Their Extracellular Ligands in Human Lymphoid Tissues”, American Journal of Pathology, vol. 143, pp. 1098-1110 (1993).
Gretz, et al., “Lymph-borne Chemokines and Other Low Molecular Weight Molecules Reach High Endothelial Venules Via Specialized Conduits While a Functional Barrier Limits Access to the Lymphocyte Microenvironments in Lymph Node Cortex”, The Journal of Experimental Medicine, vol. 192, pp. 1425-1439 (2000).
Stuart, et al., “The Human Reticular Cell: Morphology and Cytochemistry”, J. Pathol, vol. 103, pp. 41-47 (1971).
Crivellato, et al., “Stromal Cell Organisation in the Mouse Ly

Affiliated with

Also associated with

Rating

Artificial immune system: methods for making and use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Artificial immune system: methods for making and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Artificial immune system: methods for making and use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4217309